News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Merck shares fall on worries about osteoporosis drug

Started by riky, February 03, 2013, 09:00:16 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Merck shares fall on worries about osteoporosis drug

<p><a href="http://news.yahoo.com/merck-beats-forecast-issues-cautious-2013-view-121142796--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/MKY_cG4Zui7SRONykhtK5w--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-02-01T230036Z_4_CBRE9100XVO00_RTROPTP_2_SCHERINGPLOUGH-MERCK.JPG" width="130" height="86" alt="A view of the Merck &amp; Co. campus in Linden, New Jersey" align="left" title="A view of the Merck &amp; Co. campus in Linden, New Jersey" border="0" /></a>(Reuters) - Merck &amp; Co Inc's quarterly results beat estimates, but the drugmaker issued a cautious 2013 profit forecast and said it will delay seeking approval for a high-profile osteoporosis drug, sending its shares down 3 percent. Merck will not submit its osteoporosis treatment odanacatib to U.S. regulators until next year. Some analysts had predicted the medicine could generate annual sales of up to $2 billion, if approved. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login